All Stories

  1. Intrathecal drug delivery systems: an overview of cost-effectiveness evidence
  2. Systematic review and meta-analysis of intrathecal drug delivery systems for the treatment of chronic refractory non-cancer pain
  3. Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review
  4. Response to De Paepe et al.
  5. The Implementation of Persistent Spinal Pain Syndrome ( PSPS ): Mechanism‐Based Recommendations
  6. Demystifying Spinal Cord Stimulation as Not More Than a Placebo: An Evidence‐Based Perspective
  7. Treatment modalities for patients with Persistent Spinal Pain Syndrome Type II: A systematic review and network meta-analysis
  8. Systematic review and meta-analysis of conventional medical management in a patient population with refractory chronic pain suitable to receive a spinal cord stimulation system
  9. THE NEED FOR FURTHER GUIDANCE ON THE HANDLING OF MULTIPLE OUTCOMES IN RANDOMISED CONTROLLED TRIALS: A SCOPING REVIEW OF THE METHODOLOGICAL LITERATURE
  10. Reporting guidelines for protocols of randomised controlled trials of implantable neurostimulation devices: the SPIRIT-iNeurostim extension
  11. Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension
  12. Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society’s recommendations for best clinical practice
  13. Comment on ‘A sham‐controlled, randomized trial of spinal cord stimulation for the treatment of pain in chronic pancreatitis’ by Gulisano et al.
  14. Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis
  15. Limitations of the Cochrane review of spinal cord stimulation for low back pain
  16. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
  17. Issues in patient cohort, surrogate outcome measures and conflicts of interest of JAMA Neurology's Dhruva et al. propensity‐matched retrospective evaluation of a single insurer administrative claims data of spinal cord stimulation compared w...
  18. Response to Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475
  19. Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain
  20. Contact heat in Magnetoencephalography: A Systematic Review
  21. Issues in design, conduct, and conclusions of JAMA 's Hara et al.'s randomized clinical trial of spinal cord burst stimulation versus placebo stimulation on disability in patients with chronic radicular pain after lum...
  22. Health effects of liquid and gaseous fuels for household energy use: Systematic evidence mapping
  23. Ziconotide for the Management of Cancer Pain: A Budget Impact Analysis
  24. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy
  25. Association Between Levels of Functional Disability and Health-Related Quality of Life With Spinal Cord Stimulation for Chronic Pain
  26. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis
  27. Patient Selection for Spinal Cord Stimulation in Treatment of Pain: Sequential Decision-Making Model — A Narrative Review
  28. Predicting patient-reported outcomes following lumbar spine surgery: development and external validation of multivariable prediction models
  29. Systematic review and meta-analysis of predictors of return to work after spinal surgery for chronic low back and leg pain
  30. Cross‐Country Differences in Pain Medication Before and After Spinal Cord Stimulation: A Pooled Analysis of Individual Patient Data From Two Prospective Studies in the United Kingdom and Belgium
  31. Systematic Review of the Effectiveness of Machine Learning Algorithms for Classifying Pain Intensity, Phenotype or Treatment Outcomes Using Electroencephalogram Data
  32. Are cleaner cooking solutions clean enough? A systematic review and meta-analysis of particulate and carbon monoxide concentrations and exposures
  33. A prospective long-term follow-up of dorsal root ganglion stimulation for the management of chronic intractable pain
  34. Exploration of the Supraspinal Hypotheses about Spinal Cord Stimulation and Dorsal Root Ganglion Stimulation: A Systematic Review
  35. Analgesic Efficacy of “Burst” and Tonic ( 500 Hz ) Spinal Cord Stimulation Patterns: A Randomized Placebo‐Controlled Crossover Study
  36. A systematic review of health state utility values for thyroid cancer
  37. Mindfulness‐based cognitive therapy for prevention and time to depressive relapse: systematic review and network meta‐analysis
  38. Reply to Sharma et al.
  39. The Unmet Need for Intrathecal Drug Delivery Pumps for the Treatment of Cancer Pain in England: An Assessment of the Hospital Episode Statistics Database
  40. Health‐Related Quality of Life Associated With Pain Health States in Spinal Cord Stimulation for Chronic Neuropathic Pain
  41. Antibiotic therapy for pelvic inflammatory disease
  42. Advances in Neurostimulation for Chronic Pain Disorders
  43. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial
  44. A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation
  45. Pilot service evaluation of a brief psychological therapy for self‐harm in an emergency department: Hospital Outpatient Psychotherapy Engagement Service
  46. The timing and quality of antenatal care received by women attending a primary care centre in Iquitos, Peru: A facility exit survey
  47. Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol
  48. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
  49. Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
  50. Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain
  51. Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation
  52. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
  53. Correction to: Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial
  54. Protocol for a systematic review and network meta-analysis of the management of new onset atrial fibrillation in critically unwell adult patients
  55. The effect of mindfulness practice on aggression and violence levels in adults: A systematic review
  56. Randomized Placebo‐/Sham‐Controlled Trials of Spinal Cord Stimulation: A Systematic Review and Methodological Appraisal
  57. Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  58. Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  59. Biologic Drugs as Analgesics for the Management of Low Back Pain and Sciatica
  60. Trial Versus No Trial of Spinal Cord Stimulation for Chronic Neuropathic Pain: Cost Analysis in United Kingdom National Health Service
  61. Are acceptance and mindfulness-based interventions ‘value for money’? Evidence from a systematic literature review
  62. Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial
  63. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials
  64. Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  65. COMMONLY UTILIZED PHYSIOTHERAPY TREATMENT APPROACHES IN THE MANAGEMENT OF SUB-ACUTE SCIATICA: A DELPHI STUDY
  66. EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
  67. Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis
  68. Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
  69. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
  70. Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review
  71. Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations
  72. Antibiotic therapy for pelvic inflammatory disease
  73. Mindfulness-Based Interventions During Pregnancy: a Systematic Review and Meta-analysis
  74. A Spinal Cord Stimulation Service Review From a Single Centre Using a Single Manufacturer Over a 7.5 Year Follow-Up Period
  75. EDITORIAL (Thematic Selection: Spinal Neuropharmacological Agents for the Management of Pain)
  76. Biologic drugs as analgesics for the management of osteoarthritis
  77. The effects of opioids on the endocrine system: an overview
  78. Comparison of the Effects of Intermittent Boluses to Simple Continuous Infusion on Patients’ Global Perceived Effect in Intrathecal Therapy for Pain: A Randomized Double-Blind Crossover Study
  79. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
  80. Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations
  81. Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol
  82. An overview of treatment approaches for chronic pain management
  83. Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management
  84. Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation
  85. Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature
  86. Brain activity modifications following spinal cord stimulation for chronic neuropathic pain: A systematic review
  87. Electroencephalographic evoked pain response is suppressed by spinal cord stimulation in complex regional pain syndrome: a case report
  88. The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial
  89. A review of antibiotic therapy for pelvic inflammatory disease
  90. Attrition with spinal cord stimulation
  91. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
  92. Intrathecal drug delivery for the management of pain and spasticity in adults: an executive summary of the British Pain Society’s recommendations for best clinical practice
  93. COMMONLY UTILIZED PHYSIOTHERAPY TREATMENT APPROACHES IN THE MANAGEMENT OF SUB-ACUTE SCIATICA: A PILOT STUDY USING THE DELPHI PROCESS
  94. Neuropathic pain in osteoarthritis: A review of pathophysiological mechanisms and implications for treatment
  95. The Pros and Cons of Long-Term Opioid Therapy
  96. Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model
  97. Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain
  98. Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy
  99. Antibiotic therapy for pelvic inflammatory disease (PID)
  100. Qualitative exploration of psychological factors associated with spinal cord stimulation outcome
  101. Intrathecal granuloma formation as result of opioid delivery: Systematic literature review of case reports and analysis against a control group
  102. Long-term Intrathecal Drug Administration for Chronic Nonmalignant Pain
  103. Type of Interventional Pain Procedure, Body Weight, and Presence of Spinal Pathology are Determinants of the Level of Radiation Exposure for Fluoroscopically Guided Pain Procedures
  104. Exposure from fluoroscopy in theatre
  105. Influence of a latent period in QALY anaylsis: Pilot study of intrathecal drug delivery systems for chronic non-malignant pain
  106. A systematic literature review of psychological characteristics as determinants of outcome for spinal cord stimulation therapy
  107. Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment-Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine ...
  108. Cancer Pain: Part 1: Pathophysiology; Oncological, Pharmacological, and Psychological Treatments: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners
  109. Intrathecal inflammatory masses: is the yearly opioid dose increase an early indicator?